Pharma's Asian syndicate

Pharma's Asian syndicate

Pfizer, Merck, and Eli Lilly are pooling their resources to set up an independent nonprofit company to spur research into innovative treatments for cancers common in Asian populations. The new Asian Cancer Research Group will build an open-access pharmacogenomic cancer database, which will be made p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology 2010-04, Vol.28 (4), p.297-297
1. Verfasser: Perks, Bea
Format: Artikel
Sprache:eng
Schlagworte:
631/154/2426
631/61/212/1728
706/648/496
706/703/253
Agriculture
Asian people
Bioinformatics
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedical research
Biomedicine
Biotechnology
Cancer
Joint ventures
Life Sciences
news
Oncology, Experimental
Online databases
Pharmaceutical industry
Planning
R&D
Research & development
Research and development partnership
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pfizer, Merck, and Eli Lilly are pooling their resources to set up an independent nonprofit company to spur research into innovative treatments for cancers common in Asian populations. The new Asian Cancer Research Group will build an open-access pharmacogenomic cancer database, which will be made publicly available to researchers in the field.
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt0410-297b